Skip to main content

Table 2 Overview of variables of 24 h ambulatory blood pressure monitoring. Data are expressed as median (Q1-Q3)

From: Eliminating exogenous insulin therapy in patients with type 2 diabetes by duodenal ablation and GLP-1RA decreases risk scores for cardiovascular events

 

Baseline

6 months post DMR

p-value

24 h systole (mmHg)

127 (114–141)

126 (114–136)

0.194

24 h diastole (mmHg)

79 (69–86)

77 (69–85)

0.325

24 h MAP (mmHg)

101 (91–111)

99 (92–108)

0.195

Daytime systole (mmHg)

132 (119–148)

127 (115–137)

0.001

Daytime diastole (mmHg)

83 (73–89)

79 (72–86)

0.037

Daytime MAP (mmHg)

104 (95–115)

100 (93–109)

 < 0.001

Nighttime systole (mmHg)

121 (110–133)

121 (112–132)

0.667

Nighttime diastole (mmHg)

75 (65–81)

73 (64–83)

0.812

NIghttime MAP (mmHg)

97 (86–106)

96 (86–105)

0.554

24 h heart rate (beats/min)

78 (67–84)

81 (73–89)

 < 0.001

  1. Mixed effect models were used to compare measurements between baseline and 6 months post DMR
  2. DMR Duodenal Mucosal Resurfacing, 24 h 24 h, mmHg millimeter of mercury, MAP mean arterial pressure, min minute
  3. P-values ≤ 0.05 are displayed in bold
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840